Muge Celiktas
About Muge Celiktas
Muge Celiktas is a Senior Scientist at Bristol Myers Squibb in Redwood City, California, with over 10 years of experience in cancer biomarker discovery and validation.
Company
Muge Celiktas is currently employed at Bristol Myers Squibb, a renowned pharmaceutical company. She serves as a Senior Scientist in Redwood City, California. Bristol Myers Squibb is known for its commitment to innovative research and development in the field of pharmaceuticals.
Title
Muge Celiktas holds the position of Senior Scientist at Bristol Myers Squibb. Her role involves leading advanced scientific research projects, contributing to the company's goals in developing new diagnostic and therapeutic targets.
Education and Expertise
Muge Celiktas earned a Bachelor of Science (BSc) degree in Molecular Biology and Genetics from Bilkent University, where she studied from 2005 to 2010. She possesses extensive expertise in cancer biomarker discovery and validation, backed by over 10 years of experience. Her background spans across immunology, molecular biology, and proteomics.
Professional Background
Before joining Bristol Myers Squibb, Muge Celiktas worked at MD Anderson Cancer Center from 2012 to 2018 as a Senior Mass Spectrometry Specialist. Prior to that, she worked at Fred Hutch as a Research Technician II from 2010 to 2012, and also held summer internships at Fred Hutchinson Cancer Research Center (2009) and Harvard Medical School and Massachusetts General Hospital (2008). She began her career with a one-month research internship at Fred Hutch in 2010.
Achievements
Muge Celiktas has been instrumental in developing a proteomics platform for in-depth quantitative profiling. This platform is used to identify novel diagnostic and therapeutic targets through mass spectrometry. Her work has significantly contributed to advancements in cancer biomarker discovery and validation.